Evotec
The Lead In Silico Business Partner, Platform serves as the primary liaison between Evotec's Drug Discovery Platforms segment and the global In Silico & AI organization, managing demand and the in silico roadmap worldwide. This role translates platform science priorities into prioritized AI requirements, orchestrates delivery across capability units, and drives the adoption of in silico capabilities into routine operations. The position combines scientific expertise with commercial responsibilities to advance Evotec's industrialized ADMET/Safety and predictive safety differentiators.
Headquarters
Hamburg, Hamburg, Germany
Company Size
5001-10000 employees
Founded
1993
Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Evotec.
Evotec didn’t post a salary, so this is our estimate from similar listings.
Evotec plans up to 800 job cuts, four site closures in next phase of reorganization
1 day ago